|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
 |
 |
| As Of | Filer / Issuer | Symbol† (Prices  ) | Latest Filings | SIC (Latest) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As: Filer | Re: Issuer | |||||||||||
| Active in the Past Year (since 4/16/23) in Industry 2836: | |||||||||||||
| 4/1/24 |
| 10X Capital Venture Acquisition Corp. III | VCXB | NT 10-K | 425 | 2836 | |||||||
| 4/10/24 |
| 4D Molecular Therapeutics, Inc. | FDMT | ARS  | 4 | 2836 | |||||||
| 2/12/24 |
| Abcam plc | ABCZF | 15-12G | SC 13G/A | 2836 | |||||||
| 8/28/23 |
| Aceragen, Inc. [ formerly Idera Pharmaceuticals, Inc. ] | 15-12G | 4 | 2836 | ||||||||
| 9/14/23 |
| Acesis Holdings Corp. | S-1 | — | 2836 | ||||||||
| 4/4/24 |
| Achilles Therapeutics plc [ formerly Achilles Therapeutics Ltd. ] | ACHL | S-8 | SC 13G/A | 2836 | |||||||
| 4/3/24 |
| Acorda Therapeutics, Inc. | ACOR | 8-K | 4 | 2836 | |||||||
| 3/27/24 |
| Acumen Pharmaceuticals, Inc. | ABOS | S-3 | SC 13G/A | 2836 | |||||||
| 4/12/24 |
| Adaptimmune Therapeutics plc | ADAP | 8-K | SC 13D/A | 2836 | |||||||
| 4/9/24 |
| Adaptive Biotechnologies Corp. | ADPT | 8-K | 4 | 2836 | |||||||
| 4/15/24 |
| Adma Biologics, Inc. | ADMA | ARS
| 4 | 2836 | |||||||
| 4/1/24 |
| Adverum Biotechnologies, Inc. | ADVM | EFFECT | 4 | 2836 | |||||||
| 2/14/24 |
| Agentix Corp. [ formerly FairWind Energy Inc. ] | AGTX | 10-Q | UPLOAD OLD | 2836 | |||||||
| 4/8/24 |
| Agenus Inc. | AGEN | 8-K | 4 | 2836 | |||||||
| 3/29/24 |
| AIM ImmunoTech Inc. [ formerly Hemispherx Biopharma Inc. ] | AIM | 10-K | 4 | 2836 | |||||||
| 3/21/24 |
| Alector, Inc. | ALEC | 8-K | 4 | 2836 | |||||||
| 3/12/24 |
| Aligos Therapeutics, Inc. | ALGS | S-8 | 4 | 2836 | |||||||
| 6/12/23 |
| Allena Pharmaceuticals, Inc. | SEC ACTION | SC 13G/A OLD | 2836 | ||||||||
| 3/18/24 |
| Allogene Therapeutics, Inc. | ALLO | S-8 | 4 | 2836 | |||||||
| 4/4/24 |
| Allovir, Inc. | ALVR | 10-K | 4 | 2836 | |||||||
| More... Please Sign In to list all of them. | |||||||||||||
| ________ † Market: Symbols source: SEC
: Nasdaq
| |||||||||||||
|
| Description of SIC Industry 2836 — Biological Products, Except Diagnostic Substances § | |
| Establishments primarily engaged in the production of bacterial and virus vaccines, toxoids, and analogous products (such as allergenic extracts), serums, plasmas, and other blood derivatives for human or veterinary use, other than in vitro and in vivo diagnostic substances. Included in this industry are establishments primarily engaged in the production of microbiological products for other uses. Establishments primarily engaged in manufacturing in vitro and in vivo diagnostic substances are classified in Industry 2835. | |
§ SEC Filings-Review Office (FRO) Assigned Filings-Review Responsibility OLS – Office of Life Sciences |
| NAICS Code | North American Industry | SIC Codes | |
|---|---|---|---|
| |||
| 325414 | Biological Product (except Diagnostic) Manufacturing | ⇒ | 2836 |
| SIC [SEC] Industry 2836 | ⇒ | GICS [2023] Sector → Sub-Industry | |
⇑ Assigned by the SEC
| ⇓ Assigned by S&P Dow Jones Indices / MSCI |
| Sector # | → | Sub-Industry # |
|---|---|---|
| Health Care 177 | Biotechnology 149 Pharmaceuticals 6 Life Sciences Tools & Services 2 Health Care Equipment 1 Health Care Services 1 Health Care Supplies 1 | |
| Consumer Staples 1 | Packaged Foods & Meats 1 | |
| Materials 1 | Specialty Chemicals 1 | |
| Real Estate 1 | — |
| ____________ # of Major-Index Companies in both this SIC Industry and the GICS Sector / Sub-Industry. |
